Literature DB >> 22578838

Re: Cerebral neoplastic enhancing lesions: Multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting.

Pierre Desché.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22578838     DOI： 10.1016/j.ejrad.2012.04.015

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN： 0720-048X            Impact factor:   3.528


× No keyword cloud information.
  1 in total

1.  Comparison of Gadoterate Meglumine and Gadobutrol in the MRI Diagnosis of Primary Brain Tumors: A Double-Blind Randomized Controlled Intraindividual Crossover Study (the REMIND Study).

Authors:  K R Maravilla; D San-Juan; S J Kim; G Elizondo-Riojas; J R Fink; W Escobar; A Bag; D R Roberts; J Hao; C Pitrou; A J Tsiouris; E Herskovits; J B Fiebach
Journal:  AJNR Am J Neuroradiol       Date:  2017-06-29       Impact factor: 3.825
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.